Seroprevalence of hepatitis C virus: the first population-based study from Iran
Author(s) -
Shahin Merat,
Rezvan Hashemi,
Mehdi Nouraie,
Elham Jafari,
Hassan Abolghasemi,
Amir Reza Radmard,
Hanieh ZaerRezaii,
S Amini Kafiabad,
Mahtab Maghsudlu,
Akram Pourshams,
Reza Malekzadeh,
Saeed Esmaili
Publication year - 2010
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2009.11.032
Subject(s) - seroprevalence , medicine , hepatitis c , population , hepatitis c virus , prevalence , viral hepatitis , multivariate analysis , immunology , virology , serology , epidemiology , antibody , virus , environmental health
Early studies on blood donors point to a seroprevalence of approximately 0.25% for hepatitis C virus (HCV) infection in Iran. However, the true prevalence in the general population is unknown. The objective of this study was to determine the prevalence of HCV infection in the general population of Iran.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom